Ośrodek Kardiologii Inwazyjnej Ikardiasp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-03-10
Share capital
50,000.00 PLN
Registered address
Świętokrzyska 43, 20-867 Lublin, Poland
Electronic delivery address
AE:PL-91882-25148-FHCVS-21

Financials

Revenue history (in m)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 187 days for 2021). 4 of 6 audited by a statutory auditor.

  • 202514/07/2026
  • 202413/08/2025
  • 202317/07/2024
  • 202213/07/2023
  • 202118/01/2023
  • 202025/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 11.34mMedianUSD 3.20mAverageUSD 13.48m
Net profit
This companyUSD -1.19mMedianUSD 60.59kAverageUSD 247.11k
Operating costs
This companyUSD 11.13mMedianUSD 2.92mAverageUSD 12.83m
Assets
This companyUSD 12.64mMedianUSD 2.19mAverageUSD 10.93m

National Health Fund (NFZ) contracts

Ośrodek Kardiologii Inwazyjnej Ikardia has been an NFZ healthcare provider since 2008. In 2026 it is performing 5 contracts with a total value of USD 11.84m. All its contracts were worth USD 107.61m in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentlubelskie2USD 10.90m
Outpatient specialist carelubelskie3USD 940.56k

NFZ waiting lists

This company's facilities run 7 NFZ waiting lists. Waiting time forecast by NFZ, as of 21.10.2026.

ServiceWaiting time
Cardiac surgery clinicno wait
Implantation or replacement of a single-chamber pacemaker1 day
Implantation or replacement of a dual-chamber pacemaker6 days
Cardiology ward12 days
Removal of coronary artery stenosis (angioplasty)13 days

Trademarks

Ośrodek Kardiologii Inwazyjnej Ikardia holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2019.

MarkNumberClassesStatusProtected until
IKARDIAZ.50292444Protected Jul 30, 2029
MarkProtected until
IKARDIAJul 30, 2029

Authorized Representatives

Paweł Grzegorz Wójcik – Attorney-in-fact (sole)
Janusz Marceli Rdest – Attorney-in-fact (sole)
Jarosław Kazimierz Wójcik – President of the Management Board

Manner of representation

To submit declarations of will on behalf of the company, the President of the Management Board is authorised to act independently. Moreover, in the case of a multi-member management board, joint action by two other members of the management board or by one member of the management board jointly with a commercial proxy is required to submit declarations of will.

Ownership

OwnerSharesShare valueStake
Jarosław Kazimierz Wójcikage 69
99$13,371.1599%
Others
1$135.061%

Beneficial owners

Person

Subsidiaries

NameStake
89.9978%

Debt

No entries in the National Debtors Register (KRZ).

Public aid

12 public aid cases recorded, with a total value of $2,246,807.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$16,207
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,982
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$6,900

European Funds

ProjectEU co-financing
Innovative treatment method for patients with chronic total occlusion of the coronary arteries
$1.9M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2016-11-30Switch to PKD 2007
2006-03-10Entered in the register

FAQ

Last updated: 2026-07-15